{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:49:33Z","timestamp":1793108973860,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.thromres.2016.11.004","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T02:18:42Z","timestamp":1478312322000},"page":"118-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management"],"prefix":"10.1016","volume":"148","author":[{"given":"Alejandro","family":"Garcia-Horton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"Al-Ani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6869-8431","authenticated-orcid":false,"given":"Alejandro","family":"Lazo-Langner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.thromres.2016.11.004_bb0005","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/jth.12982","article-title":"Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study","volume":"13","author":"Ponto","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2016.11.004_bb0010","first-page":"133","article-title":"The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study","volume":"98","author":"Klein","year":"2000","journal-title":"Trans. Am. Ophthalmol. Soc."},{"issue":"10","key":"10.1016\/j.thromres.2016.11.004_bb0015","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archopht.1996.01100140443012","article-title":"Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study","volume":"114","author":"Mitchell","year":"1996","journal-title":"Arch. Ophthalmol."},{"issue":"5","key":"10.1016\/j.thromres.2016.11.004_bb0020","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archopht.124.5.726","article-title":"Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study","volume":"124","author":"Cugati","year":"2006","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.thromres.2016.11.004_bb0025","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archopht.126.4.513","article-title":"The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study","volume":"126","author":"Klein","year":"2008","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.004_bb0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9394(00)00709-1","article-title":"Systemic diseases associated with various types of retinal vein occlusion","volume":"131","author":"Hayreh","year":"2001","journal-title":"Am J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.thromres.2016.11.004_bb0040","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archopht.1993.01090080083022","volume":"111","year":"1993","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.thromres.2016.11.004_bb0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11739-010-0478-2","article-title":"Retinal vein occlusions: a review for the internist","volume":"6","author":"Marcucci","year":"2011","journal-title":"Intern. Emerg. Med."},{"issue":"8","key":"10.1016\/j.thromres.2016.11.004_bb0050","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ophtha.2011.04.036","article-title":"Central and hemicentral retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulants","volume":"118","author":"Hayreh","year":"2011","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.thromres.2016.11.004_bb0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archopht.1996.01100130537006","volume":"114","year":"1996","journal-title":"Arch. Ophthalmol."},{"issue":"63","key":"10.1016\/j.thromres.2016.11.004_bb0060","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1098\/rsif.2011.0177","article-title":"Role of shear stress and stretch in vascular mechanobiology","volume":"8","author":"Lu","year":"2011","journal-title":"J. R. Soc. Interface"},{"issue":"3","key":"10.1016\/j.thromres.2016.11.004_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/1043-6618(94)80049-9","article-title":"Endothelial dysfunction and dyslipidemia: possible effects of lipid lowering and lipid modifying therapy","volume":"29","author":"van Boven","year":"1994","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.thromres.2016.11.004_bb0070","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0161-6420(93)31633-7","article-title":"Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-control Study Group","volume":"100","author":"Zhao","year":"1993","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ophtha.2010.04.019","article-title":"Natural history of visual outcome in central retinal vein occlusion","volume":"118","author":"Hayreh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.thromres.2016.11.004_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/jth.13482","article-title":"Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion","author":"Becatti","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.004_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hcv088","article-title":"The role of coagulation disorders in patients with retinal vein occlusion","volume":"109","author":"Napal","year":"2016","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.thromres.2016.11.004_bb0090","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1160\/TH04-11-0768","article-title":"Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors","volume":"93","author":"Janssen","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2016.11.004_bb0095","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ophtha.2009.02.033","article-title":"Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis","volume":"116","author":"McGimpsey","year":"2009","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.thromres.2016.11.004_bb0100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.5301\/ejo.5000426","article-title":"Plasma homocysteine in patients with retinal vein occlusion","volume":"24","author":"Minniti","year":"2014","journal-title":"Eur. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.thromres.2016.11.004_bb0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.rce.2013.01.012","article-title":"Thrombophilia and vascular risk factors in retinal vein occlusion","volume":"213","author":"Napal Lecumberri","year":"2013","journal-title":"Rev. Clin. Esp."},{"issue":"20","key":"10.1016\/j.thromres.2016.11.004_bb0110","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/hc4501.098925","article-title":"Low plasma levels of vitamin B(6) are independently associated with a heightened risk of deep-vein thrombosis","volume":"104","author":"Cattaneo","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.thromres.2016.11.004_bb0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jama.279.5.359","article-title":"Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women","volume":"279","author":"Rimm","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2007.09.009","article-title":"Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels","volume":"198","author":"Sofi","year":"2008","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.thromres.2016.11.004_bb0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/ajcn\/43.5.825","article-title":"Effect of oral vitamin B6 supplementation on in vitro platelet aggregation","volume":"43","author":"Schoene","year":"1986","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.thromres.2016.11.004_bb0130","first-page":"772","article-title":"Thrombophilic risk factors in patients with central retinal vein occlusion","volume":"86","author":"Marcucci","year":"2001","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0135","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.atherosclerosis.2009.11.006","article-title":"High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion","volume":"210","author":"Sofi","year":"2010","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.thromres.2016.11.004_bb0140","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ophtha.2009.08.022","article-title":"The incidence of retinal vein occlusion in the ocular hypertension treatment study","volume":"117","author":"Barnett","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ophtha.2003.03.002","article-title":"Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion","volume":"111","author":"Hayreh","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.thromres.2016.11.004_bb0150","doi-asserted-by":"crossref","first-page":"724780","DOI":"10.1155\/2014\/724780","article-title":"Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data","volume":"2014","author":"Kolar","year":"2014","journal-title":"J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.thromres.2016.11.004_bb0155","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/archopht.126.5.692","article-title":"Retinal vein occlusion and traditional risk factors for atherosclerosis","volume":"126","author":"O'Mahoney","year":"2008","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.thromres.2016.11.004_bb0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2004.10.039","article-title":"Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the atherosclerosis risk in communities & cardiovascular health studies","volume":"112","author":"Wong","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.thromres.2016.11.004_bb0165","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.atherosclerosis.2016.02.024","article-title":"Retinal vein occlusion and risk of cerebrovascular disease and myocardial infarction: a meta-analysis of cohort studies","volume":"247","author":"Zhong","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2016.11.004_bb0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2016.04.174","article-title":"Association between retinal vein occlusion and risk of heart failure: a 12-year nationwide cohort study","volume":"217","author":"Rim","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.thromres.2016.11.004_bb0175","article-title":"Antiphospholipid antibody and risk of retinal vein occlusion: a systematic review and meta-analysis","volume":"10","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.thromres.2016.11.004_bb0180","first-page":"2437","article-title":"Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases","volume":"28","author":"Carbone","year":"2001","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0974-1208.112389","article-title":"Oral contraceptive pills: a risk factor for retinal vascular occlusion in in-vitro fertilization patients","volume":"6","author":"Aggarwal","year":"2013","journal-title":"J. Hum. Reprod. Sci."},{"issue":"5","key":"10.1016\/j.thromres.2016.11.004_bb0190","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/bjo.82.5.538","article-title":"Oral contraception and eye disease: findings in two large cohort studies","volume":"82","author":"Vessey","year":"1998","journal-title":"Br. J. Ophthalmol."},{"issue":"Pt. 1","key":"10.1016\/j.thromres.2016.11.004_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/eye.1997.11","article-title":"Sex hormone preparations and retinal vein occlusion","volume":"11","author":"Kirwan","year":"1997","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.thromres.2016.11.004_bb0200","first-page":"209","article-title":"Central retinal vein occlusion in young women: rare cases with oral contraceptive pills as a risk factor","volume":"11","author":"Thapa","year":"2009","journal-title":"Nepal Med. Coll. J."},{"issue":"6","key":"10.1016\/j.thromres.2016.11.004_bb0205","first-page":"420","article-title":"Retinal vein occlusion and obstructive sleep apnea syndrome","volume":"32","author":"JG","year":"2009","journal-title":"J. Fr. Ophtalmol."},{"issue":"12","key":"10.1016\/j.thromres.2016.11.004_bb0210","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/archophthalmol.2010.272","article-title":"Obstructive sleep apnea among patients with retinal vein occlusion","volume":"128","author":"Glacet-Bernard","year":"2010","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0215","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajo.2012.01.011","article-title":"Sleep apnea and risk of retinal vein occlusion: a nationwide population-based study of Taiwanese","volume":"154","author":"Chou","year":"2012","journal-title":"Am J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.004_bb0220","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbrc.2006.03.015","article-title":"Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo","volume":"343","author":"Greenberg","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.thromres.2016.11.004_bb0225","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1183\/09031936.00086608","article-title":"Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link","volume":"33","author":"Lavie","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2016.11.004_bb0230","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"Levi","year":"2010","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.thromres.2016.11.004_bb0235","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ophtha.2010.01.060","article-title":"Natural history of central retinal vein occlusion: an evidence-based systematic review","volume":"117","author":"McIntosh","year":"2010","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.thromres.2016.11.004_bb0240","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ophtha.2010.01.058","article-title":"Natural history of branch retinal vein occlusion: an evidence-based systematic review","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.thromres.2016.11.004_bb0245","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1445-5994.2008.01720.x","article-title":"Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management","volume":"38","author":"Yau","year":"2008","journal-title":"Intern. Med. J."},{"issue":"9","key":"10.1016\/j.thromres.2016.11.004_bb0250","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1538-7836.2010.03909.x","article-title":"Retinal vein thrombosis: pathogenesis and management","volume":"8","author":"Rehak","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2016.11.004_bb0255","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3324\/haematol.2010.023614","article-title":"Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials","volume":"95","author":"Lazo-Langner","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.thromres.2016.11.004_bb0260","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","volume":"115","year":"1997","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.004_bb0265","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02713680701851902","article-title":"Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities","volume":"33","author":"Rehak","year":"2008","journal-title":"Curr. Eye Res."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.004_bb0270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00161238","article-title":"Central retinal vein occlusion in young people","volume":"80","author":"Giuffre","year":"1992","journal-title":"Doc. Ophthalmol."},{"issue":"6","key":"10.1016\/j.thromres.2016.11.004_bb0275","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/bjo.2008.151605","article-title":"Retinal vein occlusion and the risk of acute myocardial infarction (correction of infraction): a 3-year follow-up study","volume":"93","author":"Hu","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0280","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11239-009-0388-1","article-title":"Cardiovascular risk factors and outcome in patients with retinal vein occlusion","volume":"30","author":"Di","year":"2010","journal-title":"J. Thromb. Thrombolysis"},{"issue":"2","key":"10.1016\/j.thromres.2016.11.004_bb0285","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajo.2008.08.006","article-title":"Retinal vein occlusion and the risk of stroke development: a five-year follow-up study","volume":"147","author":"Ho","year":"2009","journal-title":"Am J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.thromres.2016.11.004_bb0290","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ophtha.2006.06.061","article-title":"Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts","volume":"114","author":"Cugati","year":"2007","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0295","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcjo.2012.08.017","article-title":"10-year Framingham risk in patients with retinal vein occlusion: a systematic review and meta-analysis","volume":"48","author":"Khan","year":"2013","journal-title":"Can. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.thromres.2016.11.004_bb0300","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICU.0b013e3282fb7fb0","article-title":"The treatment of branch retinal vein occlusion with bevacizumab","volume":"19","author":"Badala","year":"2008","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.thromres.2016.11.004_bb0305","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ophtha.2006.11.011","article-title":"Interventions for central retinal vein occlusion: an evidence-based systematic review","volume":"114","author":"Mohamed","year":"2007","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0310","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11239-015-1308-1","article-title":"Guidance for the management of venous thrombosis in unusual sites","volume":"41","author":"Ageno","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"issue":"2","key":"10.1016\/j.thromres.2016.11.004_bb0315","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2009.05.007","article-title":"Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study","volume":"125","author":"Ageno","year":"2010","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3129\/i07-190","article-title":"Dalteparin in the management of recent onset central retinal vein occlusion: a comparison with acetylsalicylic acid","volume":"43","author":"Farahvash","year":"2008","journal-title":"Can. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.thromres.2016.11.004_bb0325","first-page":"418","article-title":"Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: a randomized clinical trial","volume":"11","author":"Farahvash","year":"2008","journal-title":"Arch. Iran. Med."},{"issue":"7","key":"10.1016\/j.thromres.2016.11.004_bb0330","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1177\/1076029613513320","article-title":"Risk factors and treatment strategies in patients with retinal vascular occlusions","volume":"21","author":"Chapin","year":"2015","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"5","key":"10.1016\/j.thromres.2016.11.004_bb0335","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/ejh.12099","article-title":"Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study","volume":"90","author":"Sartori","year":"2013","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2016.11.004_bb0340","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/jop.2007.0108","article-title":"Retinal and orbital venous occlusions treated with enoxaparin","volume":"24","author":"Steigerwalt","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.thromres.2016.11.004_bb0345","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/CIRCULATIONAHA.106.631457","article-title":"Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells","volume":"114","author":"Ranjbaran","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2016.11.004_bb0350","first-page":"207","article-title":"Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties","volume":"91","author":"Vignoli","year":"2006","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.thromres.2016.11.004_bb0355","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1160\/TH09-09-0626","article-title":"Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action","volume":"103","author":"Squizzato","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2016.11.004_bb0360","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ophtha.2015.10.045","article-title":"Retinal vein occlusions preferred practice pattern (r) guidelines","volume":"123","author":"Pulido","year":"2016","journal-title":"Ophthalmology"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816306168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816306168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T05:23:46Z","timestamp":1568525026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384816306168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":72,"alternative-id":["S0049384816306168"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2016.11.004","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2016.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}